Segall Bryant & Hamill, LLC Axogen, Inc. Transaction History

Segall Bryant & Hamill, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$8.38 - $17.34 $494,654 - $1.02 Million	-59,028 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$11.18 - $18.6 $298,830 - $497,159	-26,729 Reduced 31.17%	59,028 $1.06 Million
Q3 2019 Nov 12, 2019	SELL	$12.09 - $20.46 $27,395 - $46,362	-2,266 Reduced 2.57%	85,757 $1.07 Million
Q2 2019 Aug 14, 2019	BUY	$18.5 - $25.47 $37,462 - $51,576	2,025 Added 2.35%	88,023 $0
Q1 2019 May 15, 2019	SELL	$14.62 - $22.13 $9,210 - $13,941	-630 Reduced 0.73%	85,998 $0
Q4 2018 Feb 15, 2019	BUY	$17.09 - $38.25 $513,366 - $1.15 Million	30,039 Added 53.08%	86,628 $1.77 Million
Q3 2018 Nov 14, 2018	BUY	$34.05 - $55.9 $1.93 Million - $3.16 Million	56,589 New	56,589 $0

165

36.1M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $758M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.